Although some studies have shown the role of hyperinsulinemia in different cancer types [19–21], the long-term risk of exposure to high levels of insulin, especially to high levels of post-challenge insulin for cancer development is relatively understudied. The gene discussed is INS; the disease is Hyperinsulinemia.